CacheBy
Thermo Fisher Scientific VEGF Receptor 3 Polyclonal Antibody
원본

Thermo Fisher Scientific VEGF Receptor 3 Polyclonal Antibody

상품 한눈에 보기

VEGF Receptor 3에 특이적인 Rabbit Polyclonal 항체로, WB, IHC, ICC/IF에 사용 가능. 인간 FLT-4 단백질의 C-말단 합성 펩타이드로부터 유래. 액상 형태이며 4°C 단기, -20°C 장기 보관. 연구용으로 혈관 및 림프관 형성 연구에 적합.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 01. 오전 01:01
Thermo Fisher Scientific PA532409 VEGF Receptor 3 Polyclonal Antibody 500 ul pk판매 단위 pk ·
재고 확인 필요
593,400원VAT 포함 652,740원

Thermo Fisher Scientific · Thermo Fisher Scientific VEGF Receptor 3 Polyclonal Antibody

Applications and Tested Dilution

Application Tested Dilution
Western Blot (WB) 1:50
Immunohistochemistry (Paraffin) (IHC (P)) 1:100
Immunocytochemistry (ICC/IF) 1 µg/mL

Product Specifications

Specification Description
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Synthetic peptide derived from C-terminus of human FLT-4 protein
Conjugate Unconjugated
Form Liquid
Storage Conditions Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Shipping Conditions Ambient (domestic); Wet ice (international)
RRID AB_2549879

Product Specific Information

Heat-mediated antigen retrieval is recommended prior to staining, using a 10 mM citrate buffer (pH 6.0) for 10 minutes, followed by cooling at room temperature for 20 minutes.
Following antigen retrieval, incubate samples with primary antibody for 10 minutes at room temperature.
A suggested positive control is placenta or breast carcinoma.

Target Information

Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues.
Unlike VEGF, the related VEGFC stimulates the growth of lymphatic vessels through its specific lymphatic endothelial receptor VEGFR-3.
In 1998, Dumont showed that targeted inactivation of the VEGFR-3 gene in mice resulted in defective blood vessel development in early embryos.
Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation and cardiovascular failure at embryonic day 9.5.
VEGFR3 plays an essential role in the development of the embryonic cardiovascular system before the emergence of lymphatic vessels.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.